Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series.
about
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomasRecent advances in targeted therapy for Ewing sarcomaA systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcomaThe importance of treating by histological subtype in advanced soft tissue sarcoma.New therapeutic targets in soft tissue sarcoma.Trabectedin: safety and efficacy in the treatment of advanced sarcomaPPARĪ³ agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcomaEpidemiology and therapies for metastatic sarcomaEmerging therapies for adult soft tissue sarcoma.Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.Advances in the targeted therapy of liposarcoma.A comprehensive safety evaluation of trabectedin and drug-drug interactions of trabectedin-based combinations.Advances in sarcoma genomics and new therapeutic targets.New systemic therapy options for advanced sarcomas.Long-term response to first-line trabectedin in an elderly female patient with a metastatic leiomyosarcoma unfit for anthracycline.Surgery quality and tumor status impact on survival and local control of resectable liposarcomas of extremities or the trunk wall.Uterine leiomyosarcoma manifesting as a tricuspid valve mass.Molecular targeted therapies in non-GIST soft tissue sarcomas: what the radiologist needs to knowManagement of adult soft-tissue sarcoma of the extremities and trunk.Role of chemotherapy in the management of soft tissue sarcomas.Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives.Pharmacotherapy for pediatric soft-tissue sarcomas.Histology-driven chemotherapy in soft tissue sarcomas.Spermatic cord myxoid liposarcoma presenting as an incarcerated inguinal hernia: report of a case and review of literatures.Systemic management strategies for metastatic soft tissue sarcoma.Clinical and pharmacokinetic evaluation of trabectedin for the treatment of soft-tissue sarcoma.Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study.Trabectedin in the neoadjuvant treatment of high-grade pleomorphic sarcoma: report of a rare case and literature review.Safety evaluation of trabectedin in treatment of soft-tissue sarcomas.Novel systemic therapies in advanced liposarcoma: a review of recent clinical trial resultsTrabectedin, a drug acting on both cancer cells and the tumour microenvironment.Trabectedin for desmoplastic small round cell tumours: a possible treatment option?ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma.Molecular basis of differentiation therapy for soft tissue sarcomas.The safety and efficacy of trabectedin for the treatment of liposarcoma or leiomyosarcoma.Tumor calcification: a new response pattern of myxoid liposarcoma to trabectedin.Pharmacological therapies for Liposarcoma.Trabectedin for advanced soft tissue sarcomas: a single institution experience.Adjuvant therapy for high-risk soft tissue sarcoma in the adult.Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents.
P2860
Q28076210-1D070D47-AF59-44C7-8927-82766D8D4201Q28079316-0FCC9FA5-F4A2-43E2-8557-74A9FCA7C83CQ28482357-6BDD4977-8858-4B57-932F-1104A4B90931Q30240223-72766EC0-05D4-47CF-B3E6-DE25ADD70B66Q34267924-837EC532-2FE6-4944-97EF-1F3F708723BAQ34628607-51E12799-0FDE-494B-AB87-1D22A5A18307Q34635550-2DFCA7FB-AA35-4BCD-A749-9D5A36E39941Q34652142-1DFBC1F5-0572-4DF8-AA48-FF67FAE081D7Q34659806-51A75E56-51FF-4069-BF67-4DA39987A8BCQ34674564-0948D858-CFD0-46F4-BAEA-1200D622D739Q34952133-1F5F0973-86BA-4E4D-887A-11B3C0F1D42DQ35246995-389EFF15-9974-453E-A178-4C5A1384BC6EQ35993346-C31C91FB-7CB4-4F33-8348-A72F92FC22E1Q36166394-9A626356-5E4D-499F-ADDA-5DF1DA5B6FECQ36530034-E4711BF4-EDD8-4691-9105-66CBD75A591DQ36585882-FF82D296-CD16-4DC1-868A-546FEF38FE64Q36744460-4BAA2D09-6DCB-4D29-8C25-DE5D976A9112Q36819466-89777D4C-F6D2-4AEF-99B2-F37A8EB4DCC5Q37687386-1F974BE8-9ED8-4C4E-A7F8-5B126B0C3ADBQ37687389-5B673E5C-35D4-4230-BB62-FA003E2ECCCAQ37760957-58E183F6-3D88-49B0-A395-6B9BE4389C60Q37838445-D6F5AE3A-DBF1-4128-BD23-C7F0B4D7A14BQ37848174-CCACAF04-AEE8-40B4-9907-AE82624A7DFEQ37851053-B22D0BA2-C46E-4506-9D2A-7D43B79C3292Q37950516-30356FEB-54BB-4443-8564-19FE1F118E77Q37969213-8497004C-B708-43EC-9C87-C1FC473B5307Q38001658-2E8899F0-D54E-43FE-8E2B-E440CFC6D079Q38080848-0D0E3CB4-2EF9-4A87-9821-6B944CB46F01Q38128352-CDEEFAD9-C1E1-464A-BB9D-6914F70348C3Q38161734-649FD30B-6869-4776-841C-6D9986943C91Q38206366-A6D6CBEE-D8A7-4CC5-95A4-413CC2FD6B0BQ38211863-04812941-570F-4AA9-A7AA-5A40DBFD1E32Q38337608-9D20EFD2-65C7-425C-9870-FDBF927AB9AEQ38588243-B2CDB1EF-B69F-4972-9DCD-3CAD8C64D7E5Q38797843-F19B4D87-27B1-4550-8B67-F10B86EFF46CQ38964429-61675013-2C85-45E0-97FE-61769B2F569DQ38991731-F68D4046-1DBC-4A59-ADF8-AF2F7808EDF9Q39267079-64804642-763E-44AD-91B7-D7541F895459Q39401007-9646A753-1011-41B6-8EA1-6E680C7ED13AQ39497253-2EE4D7D6-FD73-489D-B695-CB9ED862B1C6
P2860
Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series.
description
2009 nĆ® lÅ«n-bĆ»n
@nan
2009 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕ”ÕµÕ«Õ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2009 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ“Õ”ÕµÕ«Õ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2009幓ć®č«ę
@ja
2009幓č«ę
@yue
2009幓č«ę
@zh-hant
2009幓č«ę
@zh-hk
2009幓č«ę
@zh-mo
2009幓č«ę
@zh-tw
2009幓č®ŗę
@wuu
name
Trabectedin in myxoid liposarc ...... f a single-institution series.
@ast
Trabectedin in myxoid liposarc ...... f a single-institution series.
@en
Trabectedin in myxoid liposarcomas
@nl
type
label
Trabectedin in myxoid liposarc ...... f a single-institution series.
@ast
Trabectedin in myxoid liposarc ...... f a single-institution series.
@en
Trabectedin in myxoid liposarcomas
@nl
prefLabel
Trabectedin in myxoid liposarc ...... f a single-institution series.
@ast
Trabectedin in myxoid liposarc ...... f a single-institution series.
@en
Trabectedin in myxoid liposarcomas
@nl
P2093
P50
P356
P1433
P1476
Trabectedin in myxoid liposarc ...... of a single-institution series
@en
P2093
C Piovesan
J C Tercero
P304
P356
10.1093/ANNONC/MDP004
P50
P577
2009-05-22T00:00:00Z